These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 9626161)

  • 1. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
    Gessl A; Waldhäusl W
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
    Gessl A; Waldhäusl W
    Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM.
    Smerdon RA; Peakman M; Hussain MJ; Alviggi L; Watkins PJ; Leslie RD; Vergani D
    Diabetes; 1993 Jan; 42(1):127-33. PubMed ID: 8420810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
    Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
    Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
    Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.
    Ilonen J; Surcel HM; Käär ML
    Clin Exp Immunol; 1991 Aug; 85(2):278-81. PubMed ID: 1677834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
    Benito JM; Zabay JM; Gil J; Bermejo M; Escudero A; Sánchez E; Fernández-Cruz E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):128-35. PubMed ID: 9052721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis.
    Neidhart M; Pataki F; Schönbächler J; Brühlmann P
    Rheumatol Int; 1996; 16(2):77-87. PubMed ID: 8853229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45 isoform expression during T cell development in the thymus.
    Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
    Eur J Immunol; 1992 Jul; 22(7):1843-50. PubMed ID: 1378021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant distribution of CD4 and CD8 lymphocyte subsets in recent-onset IDDM patients. Effect of cyclosporin.
    Chatenoud L; Volpini W; Timsit J; Boitard C; Bach JF
    Diabetes; 1993 Jun; 42(6):869-75. PubMed ID: 7684344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.
    Giordano C; De Maria R; Todaro M; Stassi G; Mattina A; Richiusa P; Galluzzo G; Pantó F; Galluzzo A
    J Clin Immunol; 1993 Jan; 13(1):68-78. PubMed ID: 8095271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accessory molecules expressed on the peripheral blood or synovial fluid T lymphocytes from patients with Sjögren's syndrome or rheumatoid arthritis.
    Ichikawa Y; Shimizu H; Yoshida M; Takaya M; Arimori S
    Clin Exp Rheumatol; 1992; 10(5):447-54. PubMed ID: 1360883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.
    Durinovic-Belló I; Schlosser M; Riedl M; Maisel N; Rosinger S; Kalbacher H; Deeg M; Ziegler M; Elliott J; Roep BO; Karges W; Boehm BO
    Diabetologia; 2004 Mar; 47(3):439-450. PubMed ID: 14745491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
    Oling V; Marttila J; Knip M; Simell O; Ilonen J
    Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.